GL1X · GenesisL1 explorer

Research workbench

Complete PCSK9 C-ter domain in complex with vhh P1.40

Analyse Complete PCSK9 C-ter domain in complex with vhh P1.40 in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
7ANQ
Type
protein
Length
349 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Proprotein convertase SUBTILISIN/KEXIN type 9; Vhh P1.40 minibody anti-cter PCSK9
EC
3.4.21.-
UniProt
Q8NBP7
Ligands
NAG, FUC, SO4
Pockets
4 · best druggability 0.72

Structure

x-ray diffraction · 2 distinct chains · 3% helix, 51% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AProprotein convertase SUBTILISIN/KEXIN type 9 (EC 3.4.21.-)protein2220% helix, 55% strandQ8NBP7
BVhh P1.40 minibody anti-cter PCSK9protein1277% helix, 46% strand—

Ligands and binding sites

  • NAG · 2-acetamido-2-deoxy-beta-D-glucopyranose · sugar · 2 copies · chains A
  • FUC · alpha-L-fucopyranose · sugar · chains A
  • SO4 · Sulfate ion · ion · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

4 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
13790.720.8455empty
21210.580.8529SO4
3780.400.7920empty
4690.360.7718empty

Interfaces

1 interface between chains.

  • A–B · 913 Ų buried · 15 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 10 disulfide, 1 glycan (disulfide, N-glycosylation).

Compared structures

  • 7ANQ · Complete PCSK9 C-ter domain in complex with VHH P1.40 · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.